Pat Mahaffy

Clovis Lung Cancer Drug Trashed at FDA Panel, CEO Exit Next?
TheStreet.com
Tue, 04/12/16 - 03:43 pm
Clovis Oncology
FDA
advisory panels
rociletinib
Pat Mahaffy